Journal
DIABETES
Volume 60, Issue 7, Pages 2000-2007Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db10-0789
Keywords
-
Categories
Funding
- National Institutes of Health [DK-83550, DK-72968, DK-56863, DK-17844, DK-70992, DK-078283]
- Cincinnati Mouse Metabolic Phenotyping Center [DK59630]
Ask authors/readers for more resources
OBJECTIVE-Cholecystokinin (CCK) is released in response to lipid intake and stimulates insulin secretion. We hypothesized that CCK deficiency would alter the regulation of insulin secretion and glucose homeostasis. RESEARCH DESIGN AND METHODS-We used quantitative magnetic resonance imaging to determine body composition and studied plasma glucose and insulin secretion of CCK gene knockout (CCK-KO) mice and their wild-type controls using intraperitoneal glucose and arginine infusions. The area of anti-insulin staining in pancreatic islets was measured by immunohistochemisty. Insulin sensitivity was assessed with euglycemic-hyperinsulemic clamps. RESULTS-CCK-KO mice fed a low-fat diet had a reduced acute insulin response to glucose but a normal response to arginine and normal glucose tolerance, associated with a trend toward greater insulin sensitivity. However, when fed a high-fat diet (HFD) for 10 weeks, CCK-KO mice developed glucose intolerance despite increased insulin sensitivity that was associated with low insulin secretion in response to both glucose and arginine. The deficiency of insulin secretion in CCK-KO mice was not associated with changes in beta-cell or islet size. CONCLUSIONS-CCK is involved in regulating insulin secretion and glucose tolerance in mice eating an HFD. The impaired insulin response to intraperitoneal stimuli that do not typically elicit CCK release suggests that this hormone has chronic effects on beta-cell adaptation to diet in addition to acute incretin actions. Diabetes 60:2000-2007, 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available